KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology InfusionBusiness Wire • 10/31/24
KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024Business Wire • 10/23/24
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth ConferenceBusiness Wire • 09/05/24
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/07/24
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 GuidanceBusiness Wire • 08/07/24
Will KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 07/31/24
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth ConferenceBusiness Wire • 07/25/24
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth AgendaBusiness Wire • 07/24/24
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024Business Wire • 07/17/24
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in JapanBusiness Wire • 07/02/24
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous InfusionBusiness Wire • 06/05/24
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology BiologicBusiness Wire • 06/04/24
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological BiologicBusiness Wire • 05/14/24
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/01/24
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue GrowthBusiness Wire • 05/01/24
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024Business Wire • 04/17/24
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 ConferenceBusiness Wire • 03/18/24